The FDA accepts Merck's (MRK) resubmission of a New Drug Application for its sugammadex sodium...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

The FDA accepts Merck's (MRK) resubmission of a New Drug Application for its sugammadex sodium injection, which is used as a muscle relaxant during surgery. The FDA rejected the original NDA for sugammadex in 2008 and asked for additional information about allergic reactions and bleeding. (PR)